RxDoctor Payments Data

Jennifer Cannon, MD

Surgery · Burlington, NCNPI 1356464846

Payments from drug & device makers

What this record shows

This record is dominated by education: $8,000 of the $11,715 with a category attached, or 68.3%. Intuitive Surgical accounts for 86.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $8,250 and has fallen 91.5% since, to $702 in 2025.

$11,715in general payments, 2019–2025

Across 87 payments — averaging $134.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$10K
  • Smith+Nephew$283
  • Organogenesis Inc.$257
  • Kerecis Limited$211
  • Next Science LLC$173
  • Progenacare Global, LLC$166
  • plus $535 from 14 others
$8,490in research payments, 2019–2025

Across 3 payments — averaging $2829.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Diagnostics Operations, Inc.$8K

What the payments were for

  • Travel & lodging$1,96617%
  • Food & beverage$1,74815%
  • Education$8,00068%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,715 in reported general payments places this provider in the 80th percentile of 970 surgery providers in North Carolina.

See all surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024
$121,909
Medicare patients
130
Services billed
2,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.32$57,308
Gentamicin Sulfate60$2,695
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav40$479
Mupirocin51$431
Doxycycline Hyclate12$174
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$166
Levofloxacin35$162
Cephalexin13$86

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$283$57,30832 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 970 surgery providers in North Carolina.

Other surgery in Burlington

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →